Table 1 Serum clinical analysis of... | American Society of Hematology

Table 1

Serum clinical analysis of hVEGFD TG mice

Mouse group	Chole, mmol/L	HDL, mmol/L	LDL, mmol/L	Trigly, mmol/L	ASAT, U/mL	Crea, μmol/L	LD, U/mL	CK, U/mL
Controls F₁	2.0 ± 0.4	1.6 ± 0.3	0.13 ± 0.04	1.5 ± 0.2	1.00 ± 0.23	12.3 ± 1.5	2.5 ± 0.5	23.5 ± 5.2
Controls F₃	0.9 ± 0.1	0.7 ± 0.1	0.13 ± 0.02	1.2 ± 0.1	1.12 ± 0.35	12.3 ± 1.5	1.6 ± 0.3	16.2 ± 2.4
Controls all	1.4 ± 0.3	1.1 ± 0.2	0.13 ± 0.02	1.3 ± 0.1	1.08 ± 0.44	12.3 ± 0.1	2.3 ± 0.3	21.2 ± 3.1
VEGF-D TG F₁	1.9 ± 0.3	1.5 ± 0.4	0.24 ± 0.02	1.1 ± 0.3	0.61 ± 0.14	11.7 ± 0.7	1.5 ± 0.2	11.9 ± 3.1
VEGF-D TG F₃	1.3 ± 0.3	1.1 ± 0.2	0.10 ± 0.02	0.8 ± 0.2	0.37 ± 0.03	9.0 ± 1.2	0.7 ± 0.1	8.5 ± 1.9
VEGF-D TG all	1.5 ± 0.2	1.2 ± 0.2	0.15 ± 0.02	1.3 ± 0.2	0.47 ± 0.06	10.9 ± 0.7	1.2 ± 0.07	11.3 ± 1.6

Mouse group	Chole, mmol/L	HDL, mmol/L	LDL, mmol/L	Trigly, mmol/L	ASAT, U/mL	Crea, μmol/L	LD, U/mL	CK, U/mL
Controls F₁	2.0 ± 0.4	1.6 ± 0.3	0.13 ± 0.04	1.5 ± 0.2	1.00 ± 0.23	12.3 ± 1.5	2.5 ± 0.5	23.5 ± 5.2
Controls F₃	0.9 ± 0.1	0.7 ± 0.1	0.13 ± 0.02	1.2 ± 0.1	1.12 ± 0.35	12.3 ± 1.5	1.6 ± 0.3	16.2 ± 2.4
Controls all	1.4 ± 0.3	1.1 ± 0.2	0.13 ± 0.02	1.3 ± 0.1	1.08 ± 0.44	12.3 ± 0.1	2.3 ± 0.3	21.2 ± 3.1
VEGF-D TG F₁	1.9 ± 0.3	1.5 ± 0.4	0.24 ± 0.02	1.1 ± 0.3	0.61 ± 0.14	11.7 ± 0.7	1.5 ± 0.2	11.9 ± 3.1
VEGF-D TG F₃	1.3 ± 0.3	1.1 ± 0.2	0.10 ± 0.02	0.8 ± 0.2	0.37 ± 0.03	9.0 ± 1.2	0.7 ± 0.1	8.5 ± 1.9
VEGF-D TG all	1.5 ± 0.2	1.2 ± 0.2	0.15 ± 0.02	1.3 ± 0.2	0.47 ± 0.06	10.9 ± 0.7	1.2 ± 0.07	11.3 ± 1.6

Chole indicates cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; Trigly, triglycerides; ASAT, aspartate aminotransferase; Crea, creatinine; LD, lactate dehydrogenase; and CK, creatine kinase.

View Large

This Feature Is Available To Subscribers Only